Sources: 
CoMind, a healthtech startup from London, has raised
$60 million in funding with backing from Plural to advance its brain monitoring technology. The funding aims to drive the adoption of brain health assessments, akin to regular blood pressure checks, making monitoring
accessible and routine.
CoMind's innovative device measures
blood flow and pressure in the brain without the need for invasive procedures, employing low-powered infrared lasers for safety and efficacy. The startup is actively recruiting for its
third clinical trial in the US to gain regulatory approval from the
FDA. Plural's Taavet Hinrikus joins the board to contribute experience from his background in fintech and strategic investment.
Dacombe expressed the company's vision, stating, "We want brain monitoring 'to become as common as having your blood pressure taken.'" This reflects an aspiration to achieve widespread acceptance of brain health monitoring.
With this funding, CoMind aims to
transform brain monitoring into a common practice, potentially improving early detection of neurological issues and enhancing public awareness about brain health. The technology represents a significant step towards integrating brain health checks into everyday medical care, striving for the same status as traditional health checks.
Sources: London-based CoMind has secured $60 million in funding from Plural to enhance its innovative brain monitoring technology, which utilizes infrared lasers to measure blood flow and pressure without invasive procedures, aiming to normalize brain health checks similar to regular blood pressure assessments.
